福安药业：公司药品研发目前以仿制药为主暂无具体创新药规划

证券之星2025-05-09

证券之星消息，福安药业(300194)05月09日在投资者关系平台上答复投资者关心的问题。

投资者提问：为了公司长远发展，公司有没有在做好仿制药的基础上研发一到两款创新药的打算

福安药业回复：您好，公司药品研发目前以仿制药为主，截止目前，公司已进入注册程序的药品研发项目暂无创新药，未来，公司将根据公司和市场实际情况，从长远发展角度，做好研发项目的选择和规划，目前暂无具体可提供的信息，谢谢！

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2534275821?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-09 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534275821","market":"fut","top_or_hot":-1,"title":"福安药业：公司药品研发目前以仿制药为主暂无具体创新药规划","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/300194\">福安药业</a>(300194)05月09日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：为了公司长远发展，公司有没有在做好仿制药的基础上研发一到两款创新药的打算</p><p>福安药业回复：您好，公司药品研发目前以仿制药为主，截止目前，公司已进入注册程序的药品研发项目暂无创新药，未来，公司将根据公司和市场实际情况，从长远发展角度，做好研发项目的选择和规划，目前暂无具体可提供的信息，谢谢！</p><p>以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>福安药业：公司药品研发目前以仿制药为主暂无具体创新药规划</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n福安药业：公司药品研发目前以仿制药为主暂无具体创新药规划\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-09 16:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2025050900021946.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，福安药业(300194)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：为了公司长远发展，公司有没有在做好仿制药的基础上研发一到两款创新药的打算福安药业回复：您好，公司药品研发目前以仿制药为主，截止目前，公司已进入注册程序的药品研发项目暂无创新药，未来，公司将根据公司和市场实际情况，从长远发展角度，做好研发项目的选择和规划，目前暂无具体可提供的信息，谢谢！以上内容为...</p>\n\n<a href=\"https://stock.stockstar.com/RB2025050900021946.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0132","symbol_name":"高送转概念","start_time":0,"source_url":"https://stock.stockstar.com/RB2025050900021946.shtml","article_id":"2534275821","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534275821","pubTimestamp":1746777787,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，福安药业(300194)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：为了公司长远发展，公司有没有在做好仿制药的基础上研发一到两款创新药的打算福安药业回复：您好，公司药品研发目前以仿制药为主，截止目前，公司已进入注册程序的药品研发项目暂无创新药，未来，公司将根据公司和市场实际情况，从长远发展角度，做好研发项目的选择和规划，目前暂无具体可提供的信息，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","300194":"福安药业","BK0132":"高送转概念","BK1161":"生物科技","BK0028":"国家队","BK1574":"生物医药B类股","BK0060":"抗癌","BK0239":"医药制造","06978":"永泰生物-B"},"translate_title":"Fuan Pharmaceutical: The company's drug research and development currently focuses on generic drugs and has no specific innovative drug plans","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"300194":1,"06978":1},"content_text":"证券之星消息，福安药业(300194)05月09日在投资者关系平台上答复投资者关心的问题。投资者提问：为了公司长远发展，公司有没有在做好仿制药的基础上研发一到两款创新药的打算福安药业回复：您好，公司药品研发目前以仿制药为主，截止目前，公司已进入注册程序的药品研发项目暂无创新药，未来，公司将根据公司和市场实际情况，从长远发展角度，做好研发项目的选择和规划，目前暂无具体可提供的信息，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534275821","isCrawlerRequest":true}